| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78f13356cb8f8c9c36e3dd71cf7a6991 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate |
2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65f4fb6a6a4b9780a1c1f313815b8700
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b203b0b1db315f8788840af7c39cac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b023761e31f850ab187cecca5f572960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30c0cfca902ef4cebbad8844b692d74e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8171b910d11e8278af6b1303da027c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a886c416370b07728b2efa27ab8c29 |
| publicationDate |
2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10031971-A1 |
| titleOfInvention |
Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride, process for their preparation and the use thereof for the manufacture of medicaments with irreversible tyrosine kinase inhibitory activity |
| abstract |
Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluorophenylamino) -7- (3-morpholin-4-yl-propoxy) - DOLLAR A quinazolin-6-yl] -acrylamide dihydrochloride are described, Process for their preparation and the use thereof for the manufacture of medicaments with irreversible tyrosine kinase inhibitory activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006000122-A1 |
| priorityDate |
2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |